SCHEMBL25896993

SCHEMBL25896993

Cc1cc2c(c(O)c1C)CCC2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.36
ALDH1A1 P00352 4/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B1 P14061 3/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 2/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
GAA P10253 1/20 0.31
ELAVL1 Q15717 1/20 0.31
TYMS P04818 1/20 0.31
MAOA P21397 2/20 0.31
MAOB P27338 2/20 0.31
PRKCI P41743 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
USP2 O75604 1/20 0.31
MAPT P10636 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1652005 0.85 CYP2C9 (0.37) PBRM1ALDH1A1CYP2C9HSD17B1KDM4E
SCHEMBL13930558 0.82 ALDH1A1 (0.35) PBRM1ALDH1A1KDM4EHPGDRXRA
SCHEMBL17060104 0.77 CYP1A2 (0.35) ALDH1A1KDM4EHPGDGAATYMS
SCHEMBL30067255 0.74 PBRM1 (0.46) PBRM1ALDH1A1CYP2C9HSD17B1KDM4E
SCHEMBL7998384 0.74 PBRM1 (0.37) PBRM1ALDH1A1CYP2C9HSD17B1KDM4E
SCHEMBL833981 0.74 ALDH1A1 (0.44) PBRM1ALDH1A1HSD17B1KDM4EHPGD
SCHEMBL30777430 0.74 ALDH1A1 (0.44) PBRM1ALDH1A1HSD17B1KDM4EHPGD
SCHEMBL25119189 0.74 UPP1 (0.39) PBRM1ALDH1A1CYP2C9KDM4EHPGD
SCHEMBL7123504 0.73 ALDH1A1 (0.33) ALDH1A1KDM4EHPGDTYMSMAPT
SCHEMBL31674224 0.73 HSD17B1 (0.39) PBRM1HSD17B1MAOAMAOBPRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242473-A1 THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242473-A1 THYROMIMETICS TPO, THOP1, THRB PBRM1 4681/4885ALDH1A1 1619/4885CYP2C9 3861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.